Portugal, Jan. 12 -- Portugal based SANDOZ FARMACEUTICA, LDA. has secured contract from Unidade Local De Saude De Almada-Seixal, Epe for Ustecinumab (Biosimilar) 90Mg/1Ml Sol Inj Ser 1 Ml Sc. The value of the contract is worth 520000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....